Payment overview · 2025
General Payments
$54.21
2 reported records · 2 companies
Healthcare provider profile · identity verified
Michael Garcia, MD
Allopathic & Osteopathic Physicians|Family Medicine · ALBUQUERQUE, NM · NPI 1700947744
Verified facts
What the public records show
CMS Open Payments records show Michael Garcia, MD received $54.21 in general payments during 2025 across 2 reported records.
Pulmonx Corporation accounted for 62.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Pulmonx Corporation | Unresolved — no canonical attribution shown | $33.93 | 62.6% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $20.28 | 37.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $54.21 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CHARTIS CATHETER Normalized: chartis catheter |
Device | Pulmonx Corporation | $33.93 | 1 | 2025 |
Source payment records
|
|||||
| PULMONX CHARTIS TABLET CONSOLE Normalized: pulmonx chartis tablet console |
Device | Pulmonx Corporation | $33.93 | 1 | 2025 |
Source payment records
|
|||||
| ZEPHYR DELIVERY CATHETER Normalized: zephyr delivery catheter |
Device | Pulmonx Corporation | $33.93 | 1 | 2025 |
Source payment records
|
|||||
| ZEPHYR ENDOBRONCHIAL VALVE Normalized: zephyr endobronchial valve |
Device | Pulmonx Corporation | $33.93 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $20.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 601 | 195 |
| Atorvastatin Calcium | Atorvastatin Calcium | 514 | 169 |
| Lisinopril | Lisinopril | 485 | 150 |
| Gabapentin | Gabapentin | 354 | 105 |
| Losartan Potassium | Losartan Potassium | 291 | 92 |
| Amlodipine Besylate | Amlodipine Besylate | 279 | 93 |
| Metformin Hcl | Metformin Hcl | 259 | 81 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 249 | 46 |
| Omeprazole | Omeprazole | 233 | 76 |
| Trazodone Hcl | Trazodone Hcl | 217 | 52 |
| Metoprolol Succinate | Metoprolol Succinate | 202 | 65 |
| Simvastatin | Simvastatin | 196 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 194 | 66 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 172 | 64 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 169 | 60 |
| Hydrochlorothiazide | Hydrochlorothiazide | 165 | 50 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 164 | 25 |
| Eliquis | Apixaban | 139 | 35 |
| Oxycodone Hcl | Oxycodone Hcl | 115 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 108 | 30 |
| Furosemide | Furosemide | 107 | 42 |
| Allopurinol | Allopurinol | 102 | 34 |
| Mirtazapine | Mirtazapine | 100 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 96 | 25 |
| Tramadol Hcl | Tramadol Hcl | 96 | 22 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 93 | 30 |
| Alprazolam | Alprazolam | 92 | 17 |
| Glipizide Er | Glipizide | 90 | 31 |
| Potassium Chloride | Potassium Chloride | 90 | 30 |
| Montelukast Sodium | Montelukast Sodium | 89 | 32 |
| Carvedilol | Carvedilol | 88 | 30 |
| Jardiance | Empagliflozin | 86 | 27 |
| Alendronate Sodium | Alendronate Sodium | 85 | 25 |
| Famotidine | Famotidine | 82 | 30 |
| Pantoprazole Sodium | Pantoprazole Sodium | 82 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 80 | 30 |
| Meloxicam | Meloxicam | 80 | 30 |
| Sertraline Hcl | Sertraline Hcl | 77 | 23 |
| Celecoxib | Celecoxib | 76 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 20 |
| Metformin Hcl Er | Metformin Hcl | 75 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 74 | 24 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 26 |
| Zolpidem Tartrate | Zolpidem Tartrate | 71 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 66 | 17 |
| Lorazepam | Lorazepam | 65 | 14 |
| Ozempic | Semaglutide | 62 | 14 |
| Pregabalin | Pregabalin | 62 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | 20 |
| Ibuprofen | Ibuprofen | 56 | 22 |
| Spironolactone | Spironolactone | 56 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 55 | 16 |
| Buspirone Hcl | Buspirone Hcl | 54 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 54 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 53 | 13 |
| Glipizide | Glipizide | 49 | 16 |
| Lovastatin | Lovastatin | 49 | 17 |
| Clonazepam | Clonazepam | 48 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | 16 |
| Morphine Sulfate Er | Morphine Sulfate | 47 | suppressed |
| Atenolol | Atenolol | 44 | 14 |
| Finasteride | Finasteride | 44 | 17 |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 44 | 15 |
| Azithromycin | Azithromycin | 43 | 38 |
| Ipratropium Bromide | Ipratropium Bromide | 43 | 18 |
| Baclofen | Baclofen | 42 | 13 |
| Trulicity | Dulaglutide | 41 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 34 |
| Bupropion Xl | Bupropion Hcl | 40 | 11 |
| Cephalexin | Cephalexin | 39 | 33 |
| Ezetimibe | Ezetimibe | 39 | 11 |
| Prednisone | Prednisone | 39 | 28 |
| Acyclovir | Acyclovir | 38 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 37 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 36 | 13 |
| Fenofibrate | Fenofibrate | 34 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 33 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | 11 |
| Diazepam | Diazepam | 30 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 30 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Risperidone | Risperidone | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | 14 |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 16 |
| Synthroid | Levothyroxine Sodium | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 24 | suppressed |
| Estradiol | Estradiol | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 16 |
| Glimepiride | Glimepiride | 23 | suppressed |
| Lactulose | Lactulose | 23 | 13 |
| Amoxicillin | Amoxicillin | 22 | 19 |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 16 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 17 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 16 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Ibu | Ibuprofen | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 12 |
| Torsemide | Torsemide | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $54.21 · 2 records | Pulmonx Corporation | CHARTIS CATHETER, PULMONX CHARTIS TABLET CONSOLE, The Cologuard Plus Collection Kit, ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error